share_log

Independent Director Of Tenet Healthcare Sold 49% Of Their Shares

Independent Director Of Tenet Healthcare Sold 49% Of Their Shares

Tenet Healthcare独立董事出售了49%的股份
Simply Wall St ·  2023/11/26 07:32

We'd be surprised if Tenet Healthcare Corporation (NYSE:THC) shareholders haven't noticed that the Independent Director, Richard Fisher, recently sold US$400k worth of stock at US$66.65 per share. The eyebrow raising move amounted to a reduction of 49% in their holding.

如果Tenet Healthcare Corporation(纽约证券交易所代码:THC)的股东没有注意到独立董事理查德·费舍尔最近以每股66.65美元的价格出售了价值40万美元的股票,我们会感到惊讶。此举使他们的持股量减少了49%。

Check out our latest analysis for Tenet Healthcare

查看我们对 Tenet Healthcare 的最新分析

Tenet Healthcare Insider Transactions Over The Last Year

去年 Tenet Healthcare 的内幕交易

In the last twelve months, the biggest single sale by an insider was when the EVP, Chief Administrative Officer, Thomas Arnst, sold US$1.5m worth of shares at a price of US$73.80 per share. So what is clear is that an insider saw fit to sell at around the current price of US$68.00. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. In this case, the big sale took place at around the current price, so it's not too bad (but it's still not a positive).

在过去的十二个月中,内部人士最大的一次出售是执行副总裁兼首席行政官托马斯·阿恩斯特以每股73.80美元的价格出售了价值150万美元的股票。因此,显而易见的是,一位内部人士认为以当前68.00美元左右的价格出售是合适的。我们通常不喜欢看到内幕抛售,但是销售价格越低,我们就越担心。在这种情况下,大甩卖是在当前价格左右进行的,因此还不错(但仍然不是积极的价格)。

In the last year Tenet Healthcare insiders didn't buy any company stock. The chart below shows insider transactions (by companies and individuals) over the last year. By clicking on the graph below, you can see the precise details of each insider transaction!

去年,Tenet Healthcare内部人士没有购买任何公司股票。下图显示了去年的内幕交易(公司和个人)。点击下图,你可以看到每笔内幕交易的确切细节!

insider-trading-volume
NYSE:THC Insider Trading Volume November 26th 2023
纽约证券交易所:THC 内幕交易量 2023 年 11 月 26 日

If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.

如果你像我一样,那么你不会想错过这份业内人士正在收购的成长型公司的免费名单。

Insider Ownership

内部所有权

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. Tenet Healthcare insiders own about US$109m worth of shares (which is 1.6% of the company). Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.

我喜欢看看内部人士在一家公司拥有多少股份,以帮助我了解他们与内部人士的一致性。较高的内部人所有权通常会使公司领导层更加关注股东的利益。Tenet Healthcare内部人士拥有价值约1.09亿美元的股份(占该公司的1.6%)。大多数股东会乐于看到这种内幕所有权,因为这表明管理层的激励措施与其他股东非常一致。

So What Do The Tenet Healthcare Insider Transactions Indicate?

那么 Tenet Healthcare 内幕交易表明了什么?

An insider sold Tenet Healthcare shares recently, but they didn't buy any. Looking to the last twelve months, our data doesn't show any insider buying. It is good to see high insider ownership, but the insider selling leaves us cautious. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. Case in point: We've spotted 3 warning signs for Tenet Healthcare you should be aware of, and 1 of them doesn't sit too well with us.

一位内部人士最近出售了Tenet Healthcare的股票,但他们没有买入任何股票。展望过去的十二个月,我们的数据并未显示任何内幕买盘。很高兴看到内幕所有权很高,但内幕抛售使我们谨慎行事。因此,这些内幕交易可以帮助我们建立有关该股的论点,但了解该公司面临的风险也值得一试。一个很好的例子:我们发现了Tenet Healthcare的3个警告信号,你应该注意,其中一个对我们来说不太合适。

Of course Tenet Healthcare may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

当然,Tenet Healthcare可能不是最值得买入的股票。因此,您可能希望看到这些免费的高质量公司集。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,内部人士是指向相关监管机构报告其交易的个人。我们目前只考虑公开市场交易和私下处置的直接利益,不包括衍生品交易或间接权益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发